SCHEMBL19909263

SCHEMBL19909263

Cc1ccc2c3ccccc3n(-c3cc(C#N)c(-c4ccncc4)cc3-n3c4ccccc4c4ccc(C)cc43)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
LMNA P02545 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
RECQL P46063 1/20 0.40
SQOR Q9Y6N5 1/20 0.38
CYP2C19 P33261 3/20 0.38
PDE5A O76074 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
PTGS1 P23219 1/20 0.38
PDE4A P27815 1/20 0.38
BLM P54132 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PDE3B Q13370 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909264 0.94 PDE3B (0.41) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL20923646 0.93 KDM4E (0.36) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL19908931 0.93 ALDH1A1 (0.40) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL19909261 0.93 ALDH1A1 (0.43) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL19919758 0.92 ALDH1A1 (0.38) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL20923137 0.92 KDM4E (0.40) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL19919726 0.91 XDH (0.36) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL19919549 0.91 MAPK14 (0.39) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL19919728 0.89 MAPK14 (0.36) ALDH1A1KDM4ELMNANPSR1MEN1
SCHEMBL20923128 0.89 KDM4E (0.43) ALDH1A1KDM4ELMNANPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 ALDH1A1 882/4885KDM4E 3845/4885LMNA 4076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.